key: cord-0885537-qzcaoluk
authors: Foster, Katharine J.; Jauregui, Emilio; Tajudeen, Bobby; Bishehsari, Faraz; Mahdavinia, Mahboobeh
title: Smell loss is a prognostic factor for lower severity of COVID-19
date: 2020-07-24
journal: Ann Allergy Asthma Immunol
DOI: 10.1016/j.anai.2020.07.023
sha: 8e44d71c2b7890f5873a31e7fee96a71bac68981
doc_id: 885537
cord_uid: qzcaoluk

nan

Coronavirus disease 2019 can present with a myriad of symptoms. 1 Guidelines 2 from China, the United Kingdom and Italy had focused screening efforts on patients with fever 3 and cough, excluding anosmia from similar scrutiny. 1 However, screening of individuals with 4 reported anosmia and dysgeusia has been associated with a greater likelihood of a positive 5 COVID-19 result than other indicator of an upper respiratory infection. [2] [3] [4] The relative predictive 6 value of presenting COVID-19 symptoms is under current investigation. [3] [4] [5] [6] This study seeks to 7 ascertain the role of smell loss in risk stratification and predicting COVID-19 patients ' 8 prognosis. 9 Adult COVID-19 positive patients evaluated at a university medical center between February 1 10 and April 3, 2020 were identified by an electronic medical records query and included in our 11 initial series. Complete data on demographic variables, clinical characteristics, COVID-19 12 symptoms, COVID-19 treatments, and clinical evaluations was retrieved. Through a pre-13 designed screening questionnaire for COVID-19, patients evaluated by telemedicine, in-person, 14 or at the emergency room were asked about their symptoms during the history taking, including 15 whether they had acute smell loss. Patients with incomplete clinical data, or those for whom 16 smell loss was not recorded, were excluded. 17

The retrieved information included demographics, BMI, comorbid conditions (asthma, allergic 18 rhinitis, chronic rhinosinusitis, eczema, food allergy), pre-existing smell dysfunction, COVID-19 19 related inflammatory laboratory values (complete blood counts, c-reactive protein, albumin, 20 creatinine, ferritin and erythrocyte subdimension rate), COVID-19 outcomes (need for 21 hospitalization, ICU admission, intubation) and development of acute respiratory disease 22 syndrome. To identify and confirm comorbidities and other clinical variables, all charts were 23 reviewed by two independent trained researchers and 20% of the charts were randomly checked 24 by the principal investigator. Data points with lack of concordant information were reviewed 25 again by an independent investigator, and if needed excluded from analysis. 26 SPSS v23 (SPSS, Inc., Chicago, IL, USA) was used for all analyses. Continuous variables' 27 results are presented in the text as mean ± SD, unless otherwise specified, and were compared 28 Table 1 ). These results remained significant after further adjustment for allergic rhinitis and 61

Our data implicates smell loss as an independent positive prognostic factor of a less severe 63 COVID-19 infection. It was significantly associated with decreased hospitalization, ICU 64 admission, intubation, and ARDS rates compared to the absence of smell loss. In further support, 65 a smaller studies of 169 and 34 COVID-19 positive patients showed an association between 66 anosmia with outpatient care as opposed to hospitalization 7 . Our data aligns with these findings. 67

Additionally, smell loss was associated with less lymphopenia and higher levels of albumin, 68 suggesting a less severe reaction to COVID-19 in patients with smell loss compared to those 69 with intact smell. our study were its retrospective nature, subjective nature of smell loss, and focused nature of the 82 data collection, which did not include subjects' current medications. 

A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19)

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study

Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19

Anosmia in COVID-19 patients

Challenges in interpreting the diagnostic performance of symptoms to predict COVID-19 status: the case of anosmia

Self-reported olfactory loss associates with outpatient clinical course in Covid-19. Int Forum Allergy Rhinol

Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol

Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19